Related Experiment Videos
Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer
Hee Jung Jun1, Sun Ha Park, Won Kee Lee
1Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
Abstract:
p73, a structural and functional homologue of p53, plays an important role in modulating cell-cycle control and apoptosis. MDM2 represses the transcriptional activity of p73 and thus attenuates its activity. Based on the interaction between p73 and MDM2 in cell-cycle control and apoptosis, we investigated the association between p73 G4C14-to-A4T14 and MDM2 309T > G polymorphisms, alone and in combination, on the risk of lung cancer in a Korean population. The p73 and MDM2 genotypes were determined in 582 lung cancer patients and in 582 healthy control subjects who were frequency-matched for age and gender. The p73 AT/AT and MDM2 309 GG genotypes were associated with a nonsignificant increased risk of lung cancer (adjusted odds ratio [OR] = 1.37, 95% confidence interval [CI] = 0.83-2.24; and adjusted OR = 1.29, 95% CI = 0.92-1.80, respectively), compared with their wild-type genotypes, respectively. When the p73 and MDM2 polymorphisms were combined, the risk of lung cancer increased in a dose-dependent manner as the number of variant alleles increased (Ptrend = 0.01). Subjects with three or four variant alleles were at a significantly increased risk of lung cancer (adjusted OR = 1.74, 95% CI = 1.11-2.74, P = 0.02) compared to subjects with zero variant allele. These results suggest an additive effect of the p73 and MDM2 variant alleles on an increased risk of lung cancer.
Insights
Genetic variations in p73 and MDM2 influence lung cancer risk. Combined variant alleles of p73 and MDM2 significantly increase lung cancer risk in a Korean population, suggesting an additive effect.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- p73, a homolog of p53, regulates cell-cycle control and apoptosis.
- MDM2 inhibits p73's transcriptional activity, impacting its function.
- Understanding genetic predispositions to lung cancer is crucial for prevention and early detection.
Purpose of the Study:
- To investigate the association between p73 (G4C14-to-A4T14) and MDM2 (309T > G) polymorphisms, individually and combined, with lung cancer risk.
- To evaluate the combined effect of these polymorphisms on lung cancer risk in a Korean population.
Main Methods:
- Case-control study involving 582 lung cancer patients and 582 healthy controls.
- Genotyping of p73 and MDM2 polymorphisms using established methods.
- Statistical analysis to determine odds ratios (OR) and confidence intervals (CI), adjusting for potential confounders.
Main Results:
- p73 AT/AT and MDM2 309 GG genotypes showed a non-significant increased risk of lung cancer individually.
- A significant, dose-dependent increase in lung cancer risk was observed with the combined presence of variant p73 and MDM2 alleles (Ptrend = 0.01).
- Individuals with three or four variant alleles had a significantly elevated risk of lung cancer (adjusted OR = 1.74, P = 0.02).
Conclusions:
- The study suggests an additive effect of p73 and MDM2 variant alleles on increased lung cancer risk.
- These genetic polymorphisms may serve as potential biomarkers for lung cancer susceptibility.
- Further research is warranted to elucidate the underlying mechanisms of this gene-gene interaction in lung carcinogenesis.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...